Heavy metal-induced immunotoxicity and its mechanisms

Yakugaku Zasshi

Volumn 129, Issue 3, 2009, Pages 305-319

  Ohsawa, Motoyasu ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Autoantibody; Cadmium; Cytokine; Heavy metal; Immunotoxicity; Polyclonal B cell activation

Indexed keywords

AUTOANTIBODY; CADMIUM; CHROMIUM; CYCLOSPORIN A; CYTOKINE; GOLD SALT; HEAVY METAL; INDOMETACIN; LEAD; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANGANESE; MERCURY; PLATINUM;

ACUTE GRAFT VERSUS HOST DISEASE; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ATOPY; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CELLULAR IMMUNITY; CONTACT ALLERGY; CROHN DISEASE; CROSS REACTION; DELAYED HYPERSENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; HYPEREOSINOPHILIA; IMMUNE COMPLEX NEPHRITIS; IMMUNOFLUORESCENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOTOXICITY; IN VITRO STUDY; INFECTION; LEISHMANIA; METABOLIC ACTIVATION; MOUSE; NEPHROTOXICITY; NONHUMAN; RECURRENT ABORTION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TUBERCULOSIS;

ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTES; CADMIUM CHLORIDE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENVIRONMENTAL POLLUTANTS; HUMANS; IMMUNIZATION; LYMPHOCYTE ACTIVATION; METALS, HEAVY; NEPHRITIS; T-LYMPHOCYTES;

EID: 63049114495     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.129.305     Document Type: Review

References (58)

1. WHO/IPCS, "Principle and Methods for Assessing Autoimmunity Associated with Exposure to Chemicals," Environmental Health Criteria 236, ed. by WHO Collaborating Center for Immunotoxicology and Allergic Hypersensitivity, Geneva, 2006, pp. 1-333.
2. Vigliani E. C., Am. Ind. Hyg. Assoc. J., 30, 329-340 (1969).
3. Berggård I., Bearn A. G., J. Biol. Chem., 243, 4095-4103 (1968).
4. Peterson P. A., Berggåard I., J. Biol. Chem., 246, 25-33 (1971).
5. Murata I., Hirono T., Saeki Y., Nakagawa S., Bull. Soc. Int. Chir., 1, 34-42 (1970).
6. Ohsawa M., Kimura M., Experientia, 29, 556-558 (1973).
7. Evrin P. E., Peterson P. A., Wide L., Berggard I., Scand. J. Clin. Lab. Invest., 28, 439-443 (1971).
8. Utakoji T., Symp. Cell. Biol., 23, 231-234 (1972).
9. Ohsawa M., Kimura M., Biochem. Biophys. Res. Commun., 91, 569-574 (1973).
10. Dean J. H., Luster M. I., Munson A. E., Amos H., "Immunotoxicology and Immunopharmacology," Raven Press, New York, 1985, pp. 1-511.
11. Guengerich F. P., Mason P. S., Mol. Pharmacol., 15, 154-164 (1979).
12. Mayo K. E., Palmiter R. D., J. Biol. Chem., 256, 2621-2624 (1981).
13. Koizumi S., Sone T., Kimura M., Otsuka F., Ohsawa M., "Metallothionein II," Experientia Suppl., Vol. 52, eds. by Kägi J. H. R., Kojima Y., Birkhauser Verlag, Basel, 1987, pp. 519-523.
14. Ohsawa M., Eisei Kagaku, 36, 255-266 (1990).
15. Joshi B. G., Dwivedi C., Powell A., Holscher M., J. Comp. Pathol., 91, 11-15 (1981).
16. Druet P., Pelletier L., Rossert J., Druet E., Hirsch F., Sapin C., "Autoimmunity and Toxicology," eds. by Kummüller M. E., Bloksma N., Seinen W., Elsevier Sci. Pub., Amsterdam, 1989, pp. 347-361.
17. Gleichmann E., Kimber I., Purchase I. F. H., Arch. Toxicol., 63, 257-273 (1989).
18. Eneström S., Hultman P., Int. Arch. Allergy Immunol., 106, 180-203 (1995).
19. Schuppe H. C., Ronnau A. C., Schmiedeberg S. V., Ruzicka T., Gleichimann E., Griem P., Clin. Dermatol., 16, 149-157 (1998).
20. Ohsawa M., Sato K., Takahashi K., Ochi T., Toxicol. Lett., 19, 29-35 (1983).
21. Ohsawa M., Masuko-Sato K., Takahashi K., Otsuka F., Toxicol. Appl. Pharmacol., 84, 379-388 (1986).
22. Otsuka F., Ohsawa M., Chem.-Biol. Interact., 78, 193-205 (1991).
23. Ohsawa M., Takahashi K., Otuka F., Clin. Exp. Immunol., 73, 98-102 (1988).
24. Bigazzi P. E., Lupus, 3, 449-453 (1994).
25. Castano P., Path. Microbiol., 37, 280-301 (1971).
26. Bernard A., Lauwerys R., Gengoux P., Mahieu P., Foidart J. M., Druet P., Weening J. J., Toxicology, 31, 307-313 (1984).
27. Weiss R. A., Madaio M. P., Tomaszewski J. E., Kelly C. J., J. Exp. Med., 180, 2239-2250 (1994).
28. Lauwerys R. R., Bernard A., Roels H., Buchet J. P., Vian C., Environ. Health Perspect., 54, 147-152 (1984).
29. Ohsawa M., Otsuka F., Takahashi K., "Trace Elements in Clinical Medicine," ed. by Tomita H., Splinger Verlag, Tokyo, 1990, pp. 165-171.
30. Ohsawa M., Prog. Clin. Biol. Res., 380, 283-298 (1993).
31. Ohsawa M., Cancer Causes Control, 8, 514-517 (1997).
32. Ohsawa M., Proceedings in II International Symposium on Occupational and Environmental Allergy and Immune Diseases '99, Chieti, Italy, April, 1999, p. 26.
33. Souroujon M., White-Scharff M. E., Andre-Schwartz J., Gefter M., Schwartz R. S., J. Immunol., 140, 4173-4179 (1988).
34. Arnett F. C., Fritzler M. J., Ahn C., Holian A., J. Rheumatol., 27, 405-410 (2000).
35. Nielsen J. B., Hultman P., Environ. Health Perspect., 110 Suppl. 5, 877-881 (2002).
36. Hirsch F., Couderc J., Sapin C., Fournie G., Druet P., Eur. J. Immunol., 12, 620-625 (1982).
37. Moore K. W., O'Garra A., Malefyt R. D., Vieira P., Mossman T. R., Ann. Rev. Immunol., 11, 165-190 (1993).
38. Romagnani S., Clin. Immunol. Immunopathol., 80, 225-235 (1996).
39. Shearer G. M., Mech. Ageing Dev., 94, 1-5 (1997).
40. Ohsawa M., Proceedings of the 6th Annual Meeting of Japanese Soc. of Immunotoxicol., Sendai, Sept. 1999, pp. 5-6.
41. Yoshino S., Murata Y., Ohsawa M., J. Immunol., 161, 6904-6908 (1998).
42. Takahashi K., Ohno R., Tsurugai A., Igarashi Y., Otsuka F., Ohsawa M., Abstracts of papers, the126th Annual Meeting of the Pharmaceutical Society of Japan, Sendai, March 2006, No. 3, p. 178.
43. Ohsawa M., Takahashi K., Proceedings of the 14th Annual Meeting of Japanese Soc. of Immunotoxicol., Kobe, Sept. 2007, p. 61.
44. Ohsawa M., Abstracts of papers, the 129th Annual Meeting of the Pharmaceutical Society of Japan, Yokohama, March 2008, No.1, p. 112.
45. Bettelli E., Carrier Y., Gao W., Korn T., Strom T. B., Oukka M., Wener H. L., Kuchroo V. K., Nature, 441, 235-238 (2006).
46. Leffel E. K., Wolf C., Poklis A., White Jr. K. L., Toxicology, 188, 233-250 (2003).
47. Pollard K. M., Pearson D. L., Hultman P., Hildebrandt B., Kono D. H., Environ. Health Perspect., 107 Suppl. 5, 729-735 (1999).
48. Lawrence D. A., Mudzinski S., Rusofsky U., Warner G., "Immunotoxicology," eds. by Berlin A., Dean J., Draper M. H., Smith E. M. B., Spreafico F., Dordrecht, Martinus-Nijehoff, 1987, pp. 293-307.
49. Hudson C. A., Cao L., Kasten-Jolly L., Kirkwood J. N., Lawrence D. A., J. Toxicol. Environ. Health, A23, 895-918 (2003).
50. Bondanza A., Zimmermann V. S., Dell'Antonio G., Cin E. D., Balestrieri G., Tincani A., Amoura Z., Piette J. C., Sabbadini M. G., Rovere-Querini P., Manfredi A. A., Arthritis Rheum., 50, 1549-1560 (2004).
51. Bigazzi P. E., Environ. Health Perspect., 107 Suppl. 5, 753-765 (1999).
52. Jacobson D. L., Gange S. J., Rose N. R., Graham N. M., Clin. Immunol. Immunopathol., 84, 223-243 (1997).
53. Mowat A. M., "Handbook of Mucosal Immunology," eds. by Ogra P. I., Mestecky J., Lann M. E., Strober W., McGhee J. R., Bienesstock J., Academic Press, San Diego, 1994, pp. 185-210.
54. Kim J.-H., Ohsawa M., Biol. Pharm. Bull., 18, 854-858 (1995).
55. Yoshino S., Ohsawa M., Sagai M., J. Pharmcol. Exp. Ther., 287, 679-683 (1998).
56. Takagi K., Teshima R., Okunuki H., Hachisuka A., Sawada J., Kojima K., Takahashi K., Ohsawa M., Yoshida T., Allergol. Int., 54, 581-587 (2005).
57. Takahashi K. Ohsawa M., Utsumi H., J. Health Sci., 48, 161-167 (2002).
58. Ohsawa M., Takahashi K., Tokunaga H., Abstract papers of the 10th International Congress of Toxicology, Tampere, Finland, June 2004, Toxicol. Appl. Pharmacol., 197, 282 (2004).